Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|March 23, 2017
Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trialsA Cholapranee, G S Hazlewood, G G Kaplan, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2016
Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitisE J Mao, G S Hazlewood, G G Kaplan, et al.
Alimentary Pharmacology & Therapeutics|August 18, 2009
Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximabC Ma, R Panaccione, S J Heitman, et al.
Alimentary Pharmacology & Therapeutics|August 18, 2009
Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel diseaseM J Shale, C H Seow, C S Coffin, et al.
The EMBO Journal|March 16, 2000
Distinct cellular receptor interactions in poliovirus and rhinovirusesL Xing, K Tjarnlund, B Lindqvist, et al.
Alimentary Pharmacology & Therapeutics|February 6, 2016
Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infectionZ Kassam, C Cribb Fabersunne, M B Smith, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 18, 2019
Reduction in surgical stoma rates in Crohn's disease: a population-based time trend analysisC Ma, A Almutairdi, D Tanyingoh, et al.
Alimentary Pharmacology & Therapeutics|July 22, 2014
The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend studyK M Reich, H-J Chang, A Rezaie, et al.
Alimentary Pharmacology & Therapeutics|March 21, 2017
The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel diseaseC H Seow, Y Leung, N Vande Casteele, et al.
Journal of Crohn'S & Colitis|November 4, 2015
Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing CholangitisD Kevans, A D Tyler, K Holm, et al.
Pageof 3